PARP1 and colitis: Results showed that PARP1−/− mice develop less severe colitis than WT mice, as shown by decreased weight loss (* p < 0.05), a higher clinical score value (* p < 0.05) and an increased colon length (** p < 0.01), (Figure 1A–C).